Formulation

Respiratory drug development lags behind other therapeutic areas, but why?

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

The nose is an open door that offers rapid access to different organs.

Could a new nasal delivery method finally get drugs to the central nervous system?

Unravelling the challenges and trends in formulation best practice – and why softgels and lipids are leading the way

Today's small molecules are increasingly complex, but generic producers must keep track of trends

Each new drug is unique and deserves a fresh approach to formulation.

Why stop at biosimilar when you can be biobetter?

When looking to do good, many companies choose to focus on children’s health, particularly in developing countries.

The potential of inhaled drug delivery goes beyond traditional respiratory medicine.